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Abstract 
Background and Purpose: 
Angiogenic factors, such as endothelial nitric oxide synthase (eNOS), are thought to 
play an important role in the repair of pulmonary emphysema (PE); yet, the correlation 
of the factors involved has not been investigated. We conducted this study to clarify the 
positive correlation between eNOS expression and alveolar repair in PE recovery.  
Methods: 
We used elastase to induce PE in rats, which were divided into Groups A (Control), B 
(G-CSF), C (PE) and D (PE + G-CSF). G-CSF was injected for 12 days, 4 weeks after 
which the alveolar walls, arterioles, and angiogenic factors including eNOS were 
examined histopathologically and by western blotting.  
Results: 
In comparing Groups A, B, C, and D, the alveolar density was 2.4+/-0.2, 2.4+/-0.1, 
1.8+/-0.1, 2.5+/-0.1 per 100 µm2, respectively (C vs. others; p<0.00001) and the number 
of arterioles was 4.5+/-1.0, 5.6+/-0.6, 3.2+/-0.5, 5.5+/-0.7 /mm2, respectively (C vs. 
others; p<0.05). Immunohistochemical staining (IHC) revealed different eNOS 
expression in Group D vs. Group C (p<0.0001) and western blotting revealed different 
eNOS, VEGF, and FLT-1 expression in Group D vs. Group C (p<0.01, p<0.05, p<0.001), 
reflecting the contribution of angiogenesis to PE repair. eNOS showed a significantly 
positive correlation to alveolar density and arteriole repair.  
Conclusion: 
Alveolar repair was correlated positively to eNOS expression by vascular regeneration 
in elastase-induced rat pulmonary emphysema. 
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Introduction 
 
Pulmonary emphysema (PE) is one of the most common causes of respiratory 
failure and a frequent cause of death. Severe PE can predispose to pneumonias and the 
perioperative management of respiratory conditions complicating severe PE is difficult 
in thoracic surgery. Postoperatively, persistent PE leads to poor pulmonary function and 
dyspnea on effort, restricting the activities of daily life. Patients who undergo lung 
resection with PE suffer even further compromised quality of life (QOL)1. PE involves 
decreased elasticity of the airway and alveolar wall destruction, including chronic 
inflammation, with remodeling of the alveolar area 2. The precise mechanisms behind 
these pathological changes and lung repair remain unclear 3. A better understanding of 
the mechanism of regeneration from PE will make lung resection safer and improve 
QOL after surgery.  
Recent studies have found that bone marrow-derived cells and angiogenic 
cytokines are related to lung repair in PE. Cytokines such as G-CSF, vascular 
endothelial growth factor (VEGF), angiopoietin-1, and erythropoietin are increased by 
the inflammation and ischemia in acute lung disease, triggering the mobilization of 
EPCs from the bone marrow to the injured lung tissue 4. The importance of vascular 
regeneration in lung repair in PE has also been shown 5-7. Endothelial nitric oxide 
synthase (eNOS), one of the most important angiogenic factors, is located downstream 
of VEGF. Reduced eNOS expression and fewer endothelial cells in the pulmonary 
vasculature of PE have been reported 8. Conversely, enhanced eNOS expression in the 
residual lung after pneumonectomy with alveolar wall regeneration has been reported 9. 
However, although the importance of eNOS expression in lung repair is recognized, the 
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correlation between direct alveolar repair and eNOS expression through 
neovascularization remains unclear. We hypothesized that alveolar repair in PE is 
positively correlated to eNOS expression by vascular regeneration. In this study, G-CSF 
was used as the angiogenic factor inducing mobilizing endothelial progenitor cells 
(EPCs) 10 and enhancing eNOS. 
 
Methods 
Animals 
The Animal Research Committee at the University of Tsukuba approved the 
experimental protocols. Rats were cared for in accordance with the Guiding Principles 
for the Care and Use of Animals based on the Helsinki Declaration of 1964. The 
6-week-old male Wistar rats (BW: 200g, n=38, Charles River Japan, Yokohama, Japan) 
were divided into four groups according to the induction of PE and the use of G-CSF 
(GRAN○R
 
, Kirin Pharma, Japan) as follows: Group A (Control; non-PE treated with 
normal saline (NS), n=9), Group B (non-PE treated with G-CSF, n=11), Group C (PE 
treated with NS, n=9), and Group D (PE treated with G-CSF, n=9).  
Surgical Procedure 
Anesthesia was induced by diethyl ether (Wako Chemicals, Japan) inhalation, 
followed by an intraperitoneal injection of pentobarbital (Somnopentyl○R : 50 mg/kg, 
Kyoritsu Seiyaku Corporation, Japan). A skin incision was made to expose the trachea, 
the front of which was punctured by a 27-gauge needle to inject porcine-derived 
elastase (200 U/kg, ELASTIN PRODUCTS COMPANY. INC, MO, U.S.A.). Rats were 
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temporarily placed upright at 70 degrees. The porcine-derived elastase was dissolved in 
0.1 ml normal saline and injected over 60 s in Groups C and D. The same volume of 
normal saline was injected in the control non-PE groups (Groups A and B). 
 
Experimental Protocol 
Three weeks after the injection of elastase, G-CSF (100 µg/kg/day) was injected 
subcutaneously for 12 days. The rats were killed 9 weeks after the injection of elastase 
and the lungs were removed and fixed with an intratracheal injection of 10% formalin 
solution under constant pressure of 20 cmH2O. We examined the specimens 
histopathologically (HE stain, eNOS immunohistochemistry) and also stored frozen 
specimens for western blotting.  
 
Examination of the Alveolar Wall and Arterioles 
PE was evaluated by the alveolar density per unit (septum frequency / 100 µm2) 
and the mean linear intercept (Lm) using modified point counting methods11, as follows: 
Alveolar density per unit (septum frequency / 100 µm2): Alveolar density was based on 
the modified point counting method of Leuwerke 9, 12. Using HE staining, the points at 
which the alveolar walls crossed the borders of 10×10 lattices were counted 
continuously. The number of crossing points was averaged by the number of lattices in 
efficient alveolar areas and this process was performed using light microscopy in 100 
magnifications. The lattices were 100 µm in size. Lattices in non-alveolar areas 
containing collapsed or inflammated alveolar areas and bronchi, cartilage, and vessels 
were eliminated (Fig. 1a). We calculated 15 randomly selected fields. 
Mean Linear Intercept (Lm): The extent of emphysematous lesions was assessed 
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by measuring the mean linear intercept (Lm) using the method of Thulbeck with 
modification 13, 14. Briefly, Lm was defined as the linear sum of all lines in all frames 
counted and divided by the number of intercepts defined as an alveolar septa 
intersecting with a counting line. A minimum of 10 fields and 200 intercepts was 
measured for each rat 15. 
Arterioles were defined as arteries more than 50 µm and less than 400 µm in 
diameter. Arterioles were evaluated by the number within 1 mm2 in each lattice (Fig.1a).  
 
Immunohistochemistry 
Paraffin-embedded sections of the lung were deparaffinized with xylene and 
rehydrated with ethanol. Antigens were activated by thermal microwave radiation. 
Sections were blocked by 3% H2O2 for 15 min and incubated overnight with anti-eNOS 
antibody (Lab Vision Corporation, Fremont, CA, USA); then for another 30 min with 
the universal immuno-peroxidase polymer for rat tissue sections (Nichirei, Tokyo, 
Japan). The antibody-polymer-peroxidase complexes were visualized using DAB 
(Simple Stain DAB solution, Nichirei, Tokyo, Japan) and nuclei were counterstained 
with hematoxylin. Images were captured using a high-resolution digital camera 
mounted on a microscope (Olympus BX-40F, Tokyo, Japan). Analysis was performed 
on approximately eight capillaries per section of the left middle lobe of each rat lung at 
1,000 times magnification. Each capillary image was converted into black and white 
using the graphic software Photoshop Element (Microsoft, Seattle, WA. USA). The 
256-grayscale value of capillary endothelial cell bodies, excluding the nuclei, was 
evaluated using the graphic software ImageJ (NIH, USA). The difference in the 
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grayscale value of each group was regarded as the difference in eNOS expression for 
semi-quantitative analysis. High grayscale values indicate a high density of eNOS. 
 
Western Blotting  
The homogenized lung tissue was lysed on ice with RIPA buffer. Samples were run 
on SDS-PAGE, using 7.5-10% polyacrylamide gel (Wako Pure Chemical Industries, Ltd, 
Osaka, Japan), and electrotransferred to a polyvinylidene diflouride (PVDF, Paul 
Corporation, Pensacola, FL, U.S.A.) filter membrane. The PVDF membrane was 
blocked for 1 h at room temperature with 1% bovine serum albumin (Wako Pure 
Chemical Industries, Ltd, Osaka, Japan) in PBS containing 0.1% Tween 20 (TPBS). 
Thereafter, the PVDF membrane was incubated overnight at 4°C with primary 
antibodies in TPBS. After washing with TPBS, the PVDF membrane was incubated 
with horseradish peroxidase-conjugated anti-rabbit antibody (GE Healthcare Japan, 
Tokyo, Japan), and diluted to 1:6000 in TPBS at room temperature for 60 min. The blots 
were visualized with an enhanced chemiluminescence detection system (Amersham 
Biosciences, UK), exposed to X-ray film, and analyzed by the graphic software, ImageJ, 
using the 256-grayscale value. The following antibodies were used: Anti-eNOS 
antibody (AnaSpec, Inc, San Jose, CA, USA), anti-VEGF antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), anti-Flt-1 antibody (Thermo Fisher Scientific, 
Fremont, CA, USA), and anti-β-actin antibody (AnaSpec, Inc. San Jose, CA, USA). 
Statistical Analysis 
All variables are expressed as means +/- SD. All groups were analyzed statistically 
by the Student’s unpaired t-test with Bonferroni correction. Specific groups were 
compared using an unpaired Student’s test. Simple linear regression analysis was 
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performed for each principal factor. A difference of p<0.05 was considered significant. 
We used the statistical software SPSS (SPSS Inc., Chicago, Ill. USA).  
 
Results 
 
Evaluation of Alveolar Change 
Alveolar Density (Septum Frequency)  
The number of alveolar density crossing points on lattices in Groups A, B, C, and 
D was 2.4+/- 0.2, 2.4+/-0.1, 1.8+/-0.1, and 2.5+/-0.1 (unit: points/100 µm2), respectively. 
There were no significant differences between Groups A and B (NS), but the number of 
lattices was significantly higher in Group D than in Group C (P<0.00001) and 
significantly lower in Group C than in the other three groups (p<0.00001; Fig. 1b). 
Mean linear intercept (Lm)  
   The Lm in Groups A, B, C, and D were 92.4 +/- 7.0, 95.2 +/- 4.7, 125.1 +/- 8.8, and 
91.7 +/- 4.4 (µm), respectively. There were no significant differences between Groups A 
and B (NS), but the Lm was significantly lower in Group D than in Group C 
(P<0.00001) and significantly higher in Group C than in the other three groups 
(p<0.00001; Fig. 1c). 
 
Number of Arterioles 
The average number of arterioles in Groups A, B, C, and D was 4.5+/- 1.0 /mm2, 
5.6+/-0.6 /mm2, 3.2+/-0.5 /mm2, and 5.5+/-0.7 /mm2, respectively Although there were 
significantly fewer arterioles in Group C than in Groups A or B, there were significantly 
more arterioles in Group D than in Group C (Group C vs. Group A, group B, and Group 
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D; p<0.05, p<0.0001, and p<0.0001, respectively; Fig. 1d). 
 
eNOS Expression According to Immunohistochemistry and Western Blotting of the 
Angiogenic Factors 
The levels of eNOS expression in the capillary endothelial cells in Groups A, B, C, 
and D were 59.1+/- 8.9, 62.9+/-13.6, 35.1+/-6.4, and 61.7+/-7.3, respectively (Group C 
vs. Groups A and D; p<0.0001, p<0.0005, respectively; Fig. 2). Enhanced eNOS 
expression in the alveolar capillaries was accompanied by a higher number of arterioles 
in Group D than in Group C (Figs 1e, 2, 3). The eNOS expression in Groups C and D 
according to western blotting was 0.13+/-0.06 and 0.6+/-0.2, respectively (p<0.01; Fig. 
3a). The VEGF expression in Groups C and D according to western blotting was 
0.13+/-0.06 and 0.70+/-0.20, respectively (p<0.05; Fig. 3b). FLT-1 expression was 
similar, being 0.25+/-0.1 in Group C vs.1.56+/-0.2 in Group D (p<0.001; Fig. 3c). 
 
Evaluation by Simple Linear Regression 
Simple linear regression analyses showed significant correlations between eNOS 
expression and alveolar wall counts, being alveolar density (r=0.648; p<0.005; Fig. 4a); 
arteriole counts and alveolar wall counts, being alveolar density (r=0.546; p<0.005; Fig. 
4b); and eNOS expression and arteriole counts (r=0.670; p<0.005; Fig. 4c). Moreover, 
e-NOS expression, the number of arterioles, and the number of alveolar walls were all 
positively correlated with each other. 
 
Discussion 
Elastase-induced emphysema is a simple experimental model, designed to allow us 
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to study emphysema16. It can be established within approximately 2 weeks and is 
particularly useful for evaluating regeneration to assess the effectiveness of drugs 
administered after the development of emphysema3. 
In this experiment, injecting elastase into the trachea induced PE by disrupting the 
alveolar wall and reducing the number of arterioles with lowered eNOS expression and 
VEGF axis. We administered G-CSF as an angiogenic promoter, resulting in the repair 
of arteriole structure and alveolar wall density. Alveolar wall density and vascular 
development (arteriole number) was found to be significantly correlated with the eNOS 
expression of the alveolar capillary endothelium. It was recently recognized that 
apoptosis of endothelium, leading to the loss of capillaries, may be a central mechanism 
in emphysema5. Other reports have described impaired endothelial function in the small 
pulmonary arteries from patients with COPD 17, 18. Accordingly, fewer arterioles were 
detected in our group C than in the other groups. 
G-CSF as a potent angiogenic promoter acts by mobilizing endothelial progenitor 
cells (EPCs) 19, which are essential for vasculogenesis 20. This activation of angiogenesis, 
might have contributed to the recovery from PE. Nitric oxide (NO) is an important 
cellular messenger molecule with pleiotropic effects including vasodilatation, 
anti-oxidation, anti-inflammation, mobilization of EPC, and neovascularization21. The 
activation of eNOS and the production of NO, which is triggered by a serine/threonine 
protein kinase (Akt) signaling axis, is one of the most potent endothelial functions 22. In 
endothelial cells, the Akt signaling axis is activated by a variety of stimuli and growth 
factors such as VEGF or angiopoietin-1 that regulate angiogenesis, endothelial cell 
survival, and vessel integrity by controlling NO synthesis 22. 
Arteriogenesis is reported to be enhanced by increased eNOS expression 23, 
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whereas G-CSF is reported to induce eNOS in endothelial cells 10. In this experiment, 
eNOS contributed to vascular regeneration in addition to the VEGF axis. In relation to 
PE, it has been speculated that eNOS is capable of regenerating the alveolar wall 9. 
Consequently, we focused on the role of eNOS in lung repair from PE from the 
following perspectives: the pleiotropic effects of NO; eNOS and NO as essential factors 
for angiogenesis; and the regenerative effects of eNOS on cells, including cells in the 
alveolar wall. 
Although eNOS expression in PE repair has been emphasized 3, 8, its correlation 
has not been proven (Fig. 4). Thus, eNOS expression in the capillaries was positively 
correlated with the number of alveolar walls and arterioles. Fig. 4 shows that the 
angiogenic effect is one of the most important aspects of eNOS in lung regeneration 
from PE. Other studies have found that statins have a protective effect on alveolar and 
capillary apoptosis in PE 8. This effect is mediated by Akt and eNOS activation 3, 7. The 
importance of the angiogenic function of eNOS on PE repair was also apparent in our 
study.  
The findings of this study provide solid evidence that eNOS plays an important 
role in vascular regeneration in lung repair. Drugs enhancing eNOS may become a 
strategy for the treatment of PE, focusing on regeneration of the pulmonary vasculature 
and may help surgical patients with PE.  
 
Conclusion 
Alveolar repair is correlated positively with eNOS expression through vascular 
regeneration in elastase-induced rat pulmonary emphysema. 
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Figure legends 
Fig.1 Alveolar walls and arterioles. a (upper section). Typical alveolar images of 
Groups A to D (HE stain, X100).  The number of alveolar walls (alveolar wall density, 
septum frequency) were counted by point counting methods. b, c. G-CSF induced a 
recovery of the alveolar walls (Group C vs. Group D).  d. The number of arterioles 
recovered significantly well following the administration of G-CSF to the rats with 
induced pulmonary emphysema (PE) (Group C vs. Group D, p<0.05).  
 
Fig.2 Immunohistochemical findings of eNOS expression. eNOS was dyed brown 
inside the vascular endothelial cells (arrow). The average 256 grayscale value of eNOS 
expression was significantly higher in the G-CSF treated rats than in the non-treated rats 
with pulmonary emphysema (PE; Group C vs. Group D, p<0.00005). 
 
Fig.3 Quantification of angiogenic factors. Pulmonary emphysema (PE) with G-CSF 
treatment significantly increased the angiogenic factors, VEGF and eNOS, vs. PE 
without G-CSF (Group C vs. D; Fig3a and 3b). Flt-1 expression showed the same 
tendency (Fig3c). 
Fig.4 Evaluation by simple linear regression. Significant correlations were found 
between the alveolar walls and eNOS expression (a), the alveolar walls and arterioles 
(b), and eNOS expression and the arterioles (c). From this series of correlations, we 
concluded that higher eNOS expression enhances alveolar repair through recovery of 
the arterioles.  
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